- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.08. | Filament Health Corp. reports Q2 results | 1 | Seeking Alpha | ||
| 11.08. | Filament Health Announces Second Quarter 2025 Financial Results And Operational Highlights | 1 | CNW | ||
| 31.07. | Filament Health Announces First-ever Compassionate Use Approval For Psilocybin In The European Union | 1 | CNW | ||
| 24.07. | Filament Health Announces Two Phase 2 Research Trials In Partnership With University College London | 1 | CNW | ||
| 08.07. | Jaguar Health, Inc.: Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health | 466 | ACCESS Newswire | Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 /
Jaguar Health, Inc.
(NASDAQ:JAGX)
... ► Artikel lesen | |
| 07.07. | Filament Health Announces Fda Authorization Of Phase 2 Clinical Trial Studying Psilocybin For Alcohol Use Disorder And Post-traumatic Stress Disorder In Veterans And First Responders | 1 | CNW | ||
| 17.06. | Filament Health Enters Into Exclusive License Agreement With University Of Alabama At Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder | 2 | CNW | ||
| 11.06. | Filament Health Announces Authorization Of Phase 2 Clinical Trial Studying Botanical Psilocybin For Prolonged Grief Disorder | 1 | CNW | ||
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 28.05. | Filament Health Announces Transition From Otcqb To Otc Pink Limited | 3 | CNW | ||
| 22.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 734 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
| 22.05. | XFRA 7QS: AUSSETZUNG/SUSPENSION | 223 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
| 20.05. | Filament Health Corp: Filament shares to delist from Cboe Canada May 21 | 1 | Stockwatch | ||
| 19.05. | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 160 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.05. | Filament Health reports Q1 results | 1 | Seeking Alpha | ||
| 09.05. | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 76 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.04. | Filament Health Corp: Filament receives U.S. FDA OK for PEX010 study | 1 | Stockwatch | ||
| 09.04. | Filament Health Announces Fda Authorization Of Phase 2 Clinical Trial Studying Pex010, The Company's Botanical Psilocybin Drug Candidate, In Opioid Use Disorder | 2 | CNW | ||
| 04.04. | Filament Health to raise C$0.9M, delist from Cboe Canada | 1 | Seeking Alpha | ||
| 04.04. | Filament Health Corp: Filament Health arranges $900,000 private placement | 2 | Stockwatch | ||
| 04.04. | Filament Health Corp.: Filament Health Announces Private Placement And Intention To Voluntarily Delist From Cboe Canada | 147 | PR Newswire | Financing driven by existing investor Negev and Filament's Board of Directors
Company also announces intention to voluntarily delist from Cboe Canada
VANCOUVER... ► Artikel lesen |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 28,060 | +0,48 % | Massive UNTERBEWERTUNG?! Bayer, SFC Energy, Veganz Group Aktie | Massive Unterbewertung bei der Veganz-Aktie? Die Transformation vom Anbieter veganer Lebensmittel zum Food-Tech-Unternehmen nimmt immer mehr Form. Die erste Lieferung der in einem revolutionären Verfahren... ► Artikel lesen | |
| AURORA CANNABIS | 4,600 | 0,00 % | Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting | NASDAQ | TSX: ACB
EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada -based... ► Artikel lesen | |
| CANOPY GROWTH | 1,520 | -0,39 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Apple, Canopy Growth & Alcon) | ||
| TILRAY BRANDS | 1,181 | -0,51 % | Kursziel 2 US-Dollar: Trumps Cannabis-Kurswechsel: Tilray-Aktie im Kursrausch | © Foto: Bebeto Matthews - APDie Cannabis-Branche in den USA steht vor einem möglichen Richtungswechsel - und Tilray könnte der große Profiteur sein. Das Analysehaus Jefferies hebt sein Kursziel an,... ► Artikel lesen | |
| INNOCAN PHARMA | 0,131 | +3,56 % | "Poster"-News: Innocan Pharma - Durchbruch auf der PAINWEEK! | ||
| CRONOS GROUP | 2,210 | -0,45 % | Why Cronos Is Skyrocketing Again Today | ||
| SYNBIOTIC | 3,115 | +3,32 % | EQS-News: SYNBIOTIC SE: Über den großen Teich: SYNBIOTIC spricht internationale Investoren mit etablierten interkontinentalen Netzwerken an | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Kooperation/Strategische Unternehmensentscheidung
Über den großen Teich: SYNBIOTIC spricht internationale Investoren mit etablierten interkontinentalen... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,620 | +1,87 % | Green Thumb Industries Announces Brand Transactions with Agrify | CHICAGO and VANCOUVER, British Columbia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,014 | +12,00 % | Christina Lake Cannabis Corp: Christina Lake to amend $960,000 in debentures | ||
| AXSOME THERAPEUTICS | 103,15 | -0,53 % | Axsome Shares Up 20% in a Month: How Should You Play the Stock? | ||
| JAGUAR HEALTH | 1,590 | -0,62 % | Jaguar Health, Inc.: Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs | Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogsCompany strategy: In discussions with multiple potential... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 108,60 | -0,55 % | Jazz Pharmaceuticals stock price target raised to $205 by Truist Securities | ||
| TRULIEVE CANNABIS | 7,705 | +3,01 % | Trulieve Cannabis Corp.: Trulieve Announces Appointment of Board Member Matthew Foulston and Chief Financial Officer Jan Reese | TALLAHASSEE, Fla., Aug. 27, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 8,150 | +1,24 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity | No treatment-related neuropsychiatric events seen to date in SAD portion of Phase 1MAD study on track for completion in Q3 2025 NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals... ► Artikel lesen | |
| CANNOVUM CANNABIS | 0,484 | +5,22 % | Cannovum Health begrüßt neuen strategischen Mehrheitsinvestor - Triple Crown Ventures wird neuer Hauptgesellschafter | Berlin (ots) - Die Cannovum Health GmbH feiert einen entscheidenden Meilenstein in ihrer Unternehmensentwicklung. Triple Crown Ventures wird neuer Mehrheitsinvestor. Mit diesem Schritt gewinnt das Unternehmen... ► Artikel lesen |
FILAMENT HEALTH CORP gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,010 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.